ESC Premium Access

Ticagrelor monotherapy after percutaneous coronary intervention in patients with concomitant diabetes mellitus and chronic kidney disease: a TWILIGHT substudy

Congress Session

About the speaker

Doctor Davide Cao

Icahn School of Medicine at Mount Sinai, New York (United States of America)
1 presentation
0 follower

4 more presentations in this session

Risk prediction in patients with classical Low-flow, low-gradient aortic stenosis undergoing TAVI

Speaker: Doctor S. Ludwig (Hamburg, DE)

Thumbnail

Implications of ESC-high tthrombotic risk features and ARC-high bleeding risk criteria on clinical outcomes in all-comer patients undergoing PCI

Speaker: Doctor H. Wang (Beijing, CN)

Thumbnail

Long-term follow-up of early leaflet thrombosis after transcatheter aortic valve replacement

Speaker: Doctor M. Hein (Freiburg, DE)

Thumbnail

Derivation and validation of a pretest probability score for deep vein thrombosis before surgery

Speaker: Doctor Y. Hamamoto (Kagoshima, JP)

Thumbnail

Access the full session

Highlights from the Young in Intervention

Speakers: Doctor D. Cao, Doctor S. Ludwig, Doctor H. Wang, Doctor M. Hein, Doctor Y. Hamamoto
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Incidence of myocardial infarction, heart failure, and cardiovascular mortality in patients with peripheral artery disease: Nationwide trends between 1997 and 2016

27 August 2021

ESC Premium Access

SGLT-2 inhibitors in patients with and without a history of heart failure: a meta-analysis

27 August 2021

ESC Premium Access

Predictive value of cardiac troponin increase after percutaneous coronary intervention: is it just a marker of disease complexity?

27 August 2021

This platform is supported by

logo Novo Nordisk